DUBLIN, Nov. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Inner Ear Diseases: Novel Drug Delivery Approaches" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

A significant proportion of the world's population is suffering from otologic diseases. Absence of any disease modifying drugs is a big unmet need in the market. The current treatment of inner ear diseases is primarily based on counselling, electric and magnetic nerve stimulations.

At the same time, there is a growing off-label use of drugs for symptomatic relief. Cochlear implants, brainstem implants and hearing aids are other commonly available options to the patients to overcome hearing damages. However, these options do suffer from several limitations such as high cost, poor sound quality, and painful surgeries (in case of implants).

The widening gap between the demand and supply of drugs is likely to provide a major impetus to the market in the coming decade. The drugs for direct delivery to inner ear are currently under development and, once approved, are likely to gain a major share of the market.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INNER EAR: AN INTRODUCTION

4. INNER EAR DRUG DELIVERY: PIPELINE ANALYSIS

5. DIRECT DRUG DELIVERY TO INNER EAR: INTRATYMPANIC, INTRACOCHLEAR, TRANSTYMPANIC AND INTRALABYRINTHINE ROUTES OF DELIVERY

6. CASE STUDIES

7. COCHLEAR IMPLANTS (BIONIC EARS)

8. INTERVIEW TRANSCRIPTS

9. CONCLUSION

10. APPENDIX 1: TABULATED DATA

11. APPENDIX 2: LIST OF COMPANIES


Companies Mentioned:

• Acousia Therapeutics
• Advanced Bionics
• Akloma Bioscience AB
• America Tinnitus Association
• Atlassian
• Audibel
• Audina
• Audio Controle
• AudioCure Pharma
• Audion Therapeutics
• Auris Medical
• Autifony Therapeutics
• Beltone
• Bionic Ear Institute
• Brainsway
• Carl Zeiss NTS GmbH
• Cerbomed
• CharlesdeGiorgio
• Chungbuk National University
• Cochlear Ltd.
• College of Medicine, Seoul, Korea
• Connect Hearing
• Cornell University
• Coselgi
• Dicton
• Electone
• Eli Lilly
• Elkon
• Emory University School of Medicine
• EstimME
• Eurion
• Flexion Therapeutics
• Fudan University
• GN Resound
• GSK
• GenVec
• Genentech
• General Hearing Instruments
• General Pharma
• Genetic Therapeutics
• Google
• Government Medical College, Amritsar (India)
• Hangzhou Nurotron
• Hansaton
• IN4 Care
• Immune Pharmaceuticals
• Inception 3
• Incube labs
• Interton
• Jichi Medical University
• John Hopkins University
• Kagoshima University
• Korea Otsuka Pharmaceutical
• Kyorin Pharmaceuticals
• Kyoto University, Japan
• Laboratories Servier
• Lincoln pharma
• MED-EL
• Macquarie University
• Masaryk University
• Mathworks
• MedGenesis
• Medical University of Vienna
• Merz Pharmaceuticals
• Micro Tech Hearing Instruments
• Microtransponder
• Miracle-Ear
• NXP Semiconductors
• National University Boramae Medical Centre
• Naval Medical Center San Diego
• Neurelec
• Neurotherapies Reset
• New York Eye and Ear Infirmary
• Novartis
• O-Ray Pharma
• Orbis Biosciences
• Oricula Therapeutics
• Oticon Medical
• Otologic Therapeutics
• Otonomy
• Panasonic
• Persona Medical
• Phafag
• Phonak
• Quark Pharma
• Resound
• Rexton
• Rion
• Roche
• Rudolf Magnus Institute of Neuroscience
• S3 Group
• SIU School of Medicine
• Sebotek
• Sensorion Pharmaceuticals
• Seoul National University College of Medicine, Seoul
• Seoul National University Hospital
• Siemens
• Solvay Pharmaceuticals
• Sonic Innovations
• Sonnovation
• Sonova Holding
• SophonoTron
• Sotex
• Sound Pharmaceuticals
• Southern Illinois University
• Stanford University
• Starkey
• Synphora AB
• The Catholic University of Korea
• Unitron
• Universidad de Valladolid y Consejo Superior de InvestigacionesCientíficas
• University College of London
• University Medical Centre Utrecht
• University at Buffalo
• University of Bath
• University of Bonn
• University of California San Francisco
• University of Heidelberg
• University of Innsbruck
• University of Kansas
• University of Maryland
• University of Melbourne
• University of Miami
• University of Michigan Health System
• University of Oklahoma Health Sciences Centre
• University of Pennsylvania School of Medicine
• University of Tampere
• University of Tübingen
• University of Veterinary Medicine Vienna, Austria
• Versant Ventures
• Widex
• William Demant Holding
• WiserBAN Consortium
• XOMA
• Xiangya Hospital of Central South University

For more information visit http://www.researchandmarkets.com/research/rxq822/inner_ear

Media Contact:

 Laura Wood , +353-1-481-1716, press@researchandmarkets.net

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/inner-ear-diseases-novel-drug-delivery-approaches-300001567.html

SOURCE Research and Markets